Quantum Dot Fluorescence Slide Platform

A platform for immune diagnosis devices based on Quantum Dot fluorescence measurement mode technology. It includes Quantum Dot labeled detection kits for enhanced sensitivity, precise analysis, and multiplex analysis capabilities. The platform offers both Gold Type and Quantum Dot Type kits with sensitivity down to ng/ml levels and 500-1,000 fold higher accuracy compared to gold standard detection methods.

Quantum dot-based detection platform for in vitro diagnostic testing of urine biomarkers. Enables multi-channel composite analysis for early detection of diabetic nephropathy and premature rupture of membranes through dry-reagent immunoassay technology. Supports both clinical laboratory quantification and point-of-care patient self-testing with mobile device image capture and server-based result analysis.

Fluorescence quantitative immunoassay platform for in vitro diagnostic testing of infectious diseases, respiratory pathogens, and gastrointestinal markers. The system enables quantitative analysis using fluorescence immunoassay technology with Class II medical device certification across multiple regulatory markets. Supports high-throughput diagnostic workflows in clinical laboratories and reference testing facilities.

A diagnostic platform for point-of-care testing (POCT) that uses immunofluorescence technology for rapid and accurate detection. The platform features precise temperature control, multiple connectivity options, and automatic sample identification to enable quick diagnostic testing.

Immunofluorescence-based diagnostic platform for detection and identification of specific antigens or antibodies in clinical samples. Provides fluorescence-based results for rapid point-of-care and laboratory testing.

Chemiluminescence diagnostic platform for quantitative and qualitative analysis of biomarkers in patient samples. Delivers sensitive detection capabilities for clinical laboratory and point-of-care applications.

A microarray-based chemiluminescence immunoassay platform using hard-substrate glass slides as carriers with covalently bound monoclonal antibodies. The platform features integrated positive and negative quality control points, multi-parameter detection with up to 56 array points, and a sandwich immunoassay methodology. It combines high-sensitivity chemiluminescence detection with high-throughput biochip technology using an integrated photoelectric sensor to read all signal points simultaneously.

A comprehensive technology platform utilizing chemiluminescence immunoassay methodology for in vitro diagnostic testing. The platform enables sensitive and specific detection of various clinical markers including reproductive, autoimmune, infectious disease, and metabolic parameters.

A fluorescence-based immunoassay platform from the POCT series designed for rapid diagnostic testing. The SF-100 platform enables high-sensitivity and high-precision immunofluorescence detection for various clinical analytes and sample types.

An easy-to-operate platform that supports whole blood direct testing with results available in as fast as 3 minutes. It offers high detection throughput of up to 450 tests per hour, includes a built-in thermal printer, and features dedicated tuberculosis detection functionality to provide efficient and reliable testing solutions for primary healthcare settings.

An indirect immunofluorescence technology platform for serological testing and antibody detection. The system is utilized for diagnosis of autoimmune and infectious diseases through fluorescence-based immunoassay methodology.

An immunolayer chromatography technology platform utilizing fluorescence detection for rapid diagnostic testing. Provides high sensitivity across multiple analyte categories including thyroid markers.